A missense polymorphism (rs11466653, Met326Thr) of toll-like receptor 10 (TLR10) is associated with tumor size of papillary thyroid carcinoma in the Korean population

Endocrine

Volumn 43, Issue 1, 2013, Pages 161-169

  Kim, Su Kang ^a   Park, Hae Jeong ^a   Hong, Il Ki ^a   Chung, Joo Ho ^a   Eun, Young Gyu ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Association study; Papillary thyroid carcinoma; Single nucleotide polymorphism; Toll like receptor; Tumor size

Indexed keywords

TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 6;

ADULT; ARTICLE; CANCER INVASION; CANCER SUSCEPTIBILITY; CERVICAL LYMPH NODE; CONTROLLED STUDY; EXON; FEMALE; GENE CLUSTER; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; THYROID PAPILLARY CARCINOMA; TOLL LIKE RECEPTOR 1 GENE; TOLL LIKE RECEPTOR 10 GENE; TOLL LIKE RECEPTOR 6 GENE; TUMOR VOLUME;

EID: 84872352748     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9783-z     Document Type: Article

References (27)

1. K.W. Jung, S. Park, H.J. Kong, Y.J. Won, J.Y. Lee, H.G. Seo, J.S. Lee, Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res. Treat. 44, 11-24 (2012)
2. A.Y. Chen, A. Jemal, E.M. Ward, Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer 115, 3801-3807 (2009)
3. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M.J. Thun, Cancer statistics, 2009. CA Cancer J. Clin. 59, 225-249 (2009)
4. M.G. Borrello, L. Alberti, A. Fischer, D. Degl'innocenti, C. Ferrario, M. Gariboldi, F. Marchesi, P. Allavena, A. Greco, P. Collini, S. Pilotti, G. Cassinelli, P. Bressan, L. Fugazzola, A. Mantovani, M.A. Pierotti, Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc. Natl Acad. Sci. USA 102, 14825-14830 (2005)
5. A. Pellegrini, N. Guinazu, L. Giordanengo, R.C. Cano, S. Gea, The role of toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan. Future Microbiol. 6, 1521-1533 (2011)
6. N. Dalgic, D. Tekin, Z. Kayaalti, T. Soylemezoglu, E. Cakir, B. Kilic, B. Kutlubay, M. Sancar, M. Odabasi, Arg753Gln polymorphism of the human toll-like receptor 2 gene from infection to disease in pediatric tuberculosis. Hum. Immunol. 72, 440-445 (2011)
7. N.S. Palikhe, S.H. Kim, J.H. Kim, P. Losol, Y.M. Ye, H.S. Park, Role of toll-like receptor 3 variants in aspirin-exacerbated respiratory disease. Allergy Asthma Immunol. Res. 3, 123-127 (2011)
8. M.L. Sales, R. Schreiber, M.C. Ferreira-Sae, M.N. Fernandes, C.S. Piveta, J.A. Cipolli, C.C. Cardoso, J.R. Matos-Souza, B. Geloneze, K.G. Franchini, W. Nadruz Jr, Toll-like receptor 6 Ser249Pro polymorphism is associated with lower left ventricular wall thickness and inflammatory response in hypertensive women. Am. J. Hypertens. 23, 649-654 (2010)
9. F.A. Castro, A. Forsti, S. Buch, H. Kalthoff, C. Krauss, M. Bauer, J. Egberts, B. Schniewind, D.C. Broering, S. Schreiber, M. Schmitt, J. Hampe, K. Hemminki, C. Schafmayer, TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur. J. Cancer 47, 1203-1210 (2011)
10. Z. Vidas, Polymorphisms in toll-like receptor genes - implications for prostate cancer development. Coll. Antropol. 34, 779-783 (2010)
11. U. Hasan, C. Chaffois, C. Gaillard, V. Saulnier, E. Merck, S. Tancredi, C. Guiet, F. Briere, J. Vlach, S. Lebecque, G. Trinchieri, E.E. Bates, Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol. 174, 2942-2950 (2005)
12. T. Chuang, R.J. Ulevitch, Identification of hTLR10: a novel human toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518, 157-161 (2001)
13. R. Medzhitov, P. Preston-Hurlburt, C.A. Janeway Jr, A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 388, 394-397 (1997)
14. X. Du, A. Poltorak, Y. Wei, B. Beutler, Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11, 362-371 (2000)
15. O. Takeuchi, T. Kawai, P.F. Muhlradt, M. Morr, J.D. Radolf, A. Zychlinsky, K. Takeda, S. Akira, Discrimination of bacterial lipoproteins by toll-like receptor 6. Int. Immunol. 13, 933-940 (2001)
16. O. Takeuchi, S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, R.L. Modlin, S. Akira, Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169, 10-14 (2002)
17. A. Ozinsky, D.M. Underhill, J.D. Fontenot, A.M. Hajjar, K.D. Smith, C.B. Wilson, L. Schroeder, A. Aderem, The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl Acad. Sci. USA 97, 13766-13771 (2000)
18. S. Janssens, R. Beyaert, Role of toll-like receptors in pathogen recognition. Clin. Microbiol. Rev. 16, 637-646 (2003)
19. S. Lindstrom, D.J. Hunter, H. Gronberg, P. Stattin, F. Wiklund, J. Xu, S.J. Chanock, R. Hayes, P. Kraft, Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies. Cancer Epidemiol. Biomarkers Prev. 19, 873-876 (2010)
20. S.L. Zheng, K. Augustsson-Balter, B. Chang, M. Hedelin, L. Li, H.O. Adami, J. Bensen, G. Li, J.E. Johnasson, A.R. Turner, T.S. Adams, D.A. Meyers, W.B. Isaacs, J. Xu, H. Gronberg, Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. Cancer Res. 64, 2918-2922 (2004)
21. J. Sun, F. Wiklund, S.L. Zheng, B. Chang, K. Balter, L. Li, J.E. Johansson, G. Li, H.O. Adami, W. Liu, A. Tolin, A.R. Turner, D.A. Meyers, W.B. Isaacs, J. Xu, H. Gronberg, Sequence variants in toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J. Natl. Cancer Inst. 97, 525-532 (2005)
22. M. Canadas Garre, M. Lopez de la Torre Casares, P. Becerra Massare, M.A. Lopez Nevot, J. Villar Del Moral, N. Munoz Perez, R. Vilchez Joya, R. Montes Ramirez, J.M. Llamas Elvira, BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma. Endocrinol. Nutr. 58, 175-184 (2011)
23. R. Iuliano, D. Palmieri, H. He, A. Iervolino, E. Borbone, P. Pallante, A. Cianflone, R. Nagy, H. Alder, G.A. Calin, F. Trapasso, C. Giordano, C.M. Croce, A. de la Chapelle, A. Fusco, Role of PTPRJ genotype in papillary thyroid carcinoma risk. Endocr. Relat. Cancer 17, 1001-1006 (2010)
24. A. Salajegheh, R.A. Smith, K. Kasem, V. Gopalan, M.R. Nassiri, R. William, A.K. Lam, Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes. Eur. J. Surg. Oncol. 37, 93-99 (2011)
25. N. Kurtulmus, M. Duren, U. Ince, M. Cengiz Yakicier, O. Peker, O. Aydin, E. Altiok, S. Giray, H. Azizlerli, BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness. Endocrine 42, 404-410 (2012)
26. M.P. Purdue et al., A pooled investigation of toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 30, 275-281 (2009)
27. V.L. Stevens, A.W. Hsing, J.T. Talbot, S.L. Zheng, J. Sun, J. Chen, M.J. Thun, J. Xu, E.E. Calle, C. Rodriguez, Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int. J. Cancer 123, 2644-2650 (2008)